Pill Identifier App

Clinical Trials Update: Feb. 28, 2008

-- Here are the latest clinical trials, courtesy of Thomson CenterWatch:


This study will evaluate use of sumatriptan or naratriptan among pregnant women. Candidates must document the use of either drug during pregnancy.

The research sites are located across the United States.

More information

Please see http://www.centerwatch.com/patient/studies/cat187.html.



If you have been diagnosed with epilepsy with simple partial seizures or complex partial seizures, have had 2-to-40 seizures over a 28-day period, and are on a stable dose of one or two marketed antiepileptic drugs, you may qualify for this study.

The research site is in Grand Rapids, Mich.

More information

Please see http://www.centerwatch.com/patient/studies/cat62.html.


Seizure Disorders

If you have either completed the double-blind trial, SP902, or met the exit criteria for that trial, you may be eligible to participate in this additional study.

The research site is in Pikesville, Md.

More information

Please see http://www.centerwatch.com/patient/studies/cat138.html.


Copyright 2008 CenterWatch. All rights reserved.

Posted: February 2008

View comments